STOCK AVAILABILITY OF ZYPREXA RELPREVV: We appreciate the importance of maintaining regular supply of Zyprexa to patients in Australia.
While we can confirm that stock for this product is available in the country, it is important to note that supplies are currently limited. We are actively supplying wholesalers, hospitals, pharmacies, and other relevant channels. The quantity restrictions initiated by Eli Lilly prior to our ownership remain in effect and are compounded by on-going global supply constraints and increased product usage.
Major wholesalers are receiving periodic replenishment orders as we receive stock from Eli Lilly manufacturing sites.
If you require information about a specific order, we recommend you check with your wholesaler in the first instance. Should you have any specific questions, please provide your e-mail address, and contact phone number to email@example.com. A designated team member will contact you within the next 48 – 72 hours.
We sincerely apologize for any inconvenience this may have caused, and our teams are diligently working to resolve the situation.
Pharmaco partners with a number of international pharmaceutical companies and together we share a common goal, to provide research-based medicines that effectively treat medical conditions and enhance people’s lives. Product Information and Consumer Medicine Information for the medicines that Pharmaco supplies to the Australian market are provided below:
The Consumer Medicine Information (CMI) provides information which can help patients use their medicines effectively. Patients should always talk to their health care professional for advice on medicines or other related health matters.
The Product Information (PI) is a detailed document intended to assist doctors, pharmacists and other health care professionals in prescribing and dispensing medicines. If you are not a health care professional, it should be read in consultation with your doctor to assist with the interpretation of the content.